Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Nadal

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Nature Reviews. Clinical Oncology|December 6, 2017
Urothelial cancer in 2017: Changes in expectations for metastatic urothelial carcinomaJoaquim Bellmunt, Rosa Nadal
Future Oncology (London, England)|February 4, 2016
The evolving role of enzalutamide on the treatment of prostate cancerRosa Nadal, Joaquim Bellmunt
Med (New York, N.Y.)|June 15, 2024
Enfortumab vedotin and pembrolizumab combination as a relevant game changer in urothelial carcinoma: What is left behind?Joaquim Bellmunt, Rosa Nadal
The Journal of Urology|April 22, 2020
Editorial CommentRosa Nadal, Joaquim Bellmunt
Cancer Treatment Reviews|April 29, 2019
Management of metastatic bladder cancerRosa Nadal, Joaquim Bellmunt
Current Treatment Options in Oncology|January 14, 2014
New treatments for bladder cancer: when will we make progress?Rosa Nadal, Joaquim Bellmunt
Current Treatment Options in Oncology|May 30, 2018
Overview of Current and Future Adjuvant Therapy for Muscle-Invasive Urothelial CarcinomaRosa Nadal, Andrea B Apolo
The American Journal of Medicine|May 28, 2017
Acquired Generalized Lipodystrophy Following Immune ThrombocytopeniaJulia Cunningham, Rosa Nadal, Catherine Broome
Future Oncology (London, England)|February 25, 2014
Enzalutamide for the treatment of prostate cancer: results and implications of the AFFIRM trialRosa Nadal, Mary-Ellen Taplin, Joaquim Bellmunt
Nature Reviews. Clinical Oncology|November 9, 2023
Progress in systemic therapy for advanced-stage urothelial carcinomaRosa Nadal, Begoña P Valderrama, Joaquim Bellmunt
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Nature Reviews. Clinical Oncology|December 6, 2017
Urothelial cancer in 2017: Changes in expectations for metastatic urothelial carcinomaJoaquim Bellmunt, Rosa Nadal
Future Oncology (London, England)|February 4, 2016
The evolving role of enzalutamide on the treatment of prostate cancerRosa Nadal, Joaquim Bellmunt
Med (New York, N.Y.)|June 15, 2024
Enfortumab vedotin and pembrolizumab combination as a relevant game changer in urothelial carcinoma: What is left behind?Joaquim Bellmunt, Rosa Nadal
The Journal of Urology|April 22, 2020
Editorial CommentRosa Nadal, Joaquim Bellmunt
Cancer Treatment Reviews|April 29, 2019
Management of metastatic bladder cancerRosa Nadal, Joaquim Bellmunt
Current Treatment Options in Oncology|January 14, 2014
New treatments for bladder cancer: when will we make progress?Rosa Nadal, Joaquim Bellmunt
Current Treatment Options in Oncology|May 30, 2018
Overview of Current and Future Adjuvant Therapy for Muscle-Invasive Urothelial CarcinomaRosa Nadal, Andrea B Apolo
The American Journal of Medicine|May 28, 2017
Acquired Generalized Lipodystrophy Following Immune ThrombocytopeniaJulia Cunningham, Rosa Nadal, Catherine Broome
Future Oncology (London, England)|February 25, 2014
Enzalutamide for the treatment of prostate cancer: results and implications of the AFFIRM trialRosa Nadal, Mary-Ellen Taplin, Joaquim Bellmunt
Nature Reviews. Clinical Oncology|November 9, 2023
Progress in systemic therapy for advanced-stage urothelial carcinomaRosa Nadal, Begoña P Valderrama, Joaquim Bellmunt
Pageof 5